First-Ever vagus nerve gene injection aims to tame rare nerve disease
NCT ID NCT07543991
First seen Apr 22, 2026 · Last updated May 01, 2026 · Updated 3 times
Summary
This early-stage trial tests a gene therapy injected directly into the left vagus nerve for people with giant axonal neuropathy (GAN), a rare and fatal nerve disease. Only 4 participants who previously received a spinal injection of the same therapy are eligible. The main goal is to check safety, with a secondary focus on whether it can stabilize or improve symptoms of the autonomic nervous system.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GIANT AXONAL NEUROPATHY (GAN) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Children's Health
RECRUITINGDallas, Texas, 75235, United States
Conditions
Explore the condition pages connected to this study.